# FDA Inspection 1167083 - Jane L. Rohlf, MD - March 31, 2022

Source: https://www.keypedia.com/records/fda_inspections/jane-l-rohlf-md/2f3a86d4-25c2-4260-9f23-9413abfb9b1a
Source feed: FDA_Inspections

> FDA Inspection 1167083 for Jane L. Rohlf, MD on March 31, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1167083
- Company Name: Jane L. Rohlf, MD
- Inspection Date: 2022-03-31
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1054870 - 2018-06-01](https://www.keypedia.com/records/fda_inspections/jane-l-rohlf-md/d5447537-2d31-47e8-8d5d-d14ab4f7cdb3)
- [FDA Inspection 983479 - 2016-07-19](https://www.keypedia.com/records/fda_inspections/jane-l-rohlf-md/339ff2c0-ddb6-4ba2-a859-609714626f04)

Company: https://www.keypedia.com/companies/jane-l-rohlf-md/50dba018-a2d4-447a-8743-df5b438e8a30

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c